W2 Flashcards
1
Q
RBC: NUCLEUS
A
ANUCLEATE
2
Q
RBC: SHAPE
A
BICONCAVE/DISCOID
3
Q
RBC CONTAINS REDDISH PROTEIN CALLED
A
HEMOGLOBIN
4
Q
RBC: COLOR AND SIZE
A
SALMON PINK, 7-8MM
5
Q
RBC: ZONE OF PALLOR
A
1/3 OF CENTER
6
Q
LOSS OF OXYGEN CARRYING CAPACITY
DECREASED RBC COUNT
DECREASED RBC HEMOGLOBIN CONCENTRATION
A
ANEMIA
7
Q
INCREASED RBC COUNT CAUSING HYPERVISCOCITY
INCREASED RBC COUNT
INCREASED RBC MASS
A
POLYCTHEMIA
8
Q
RELIES ON DRABKIN REAGENT
A
HEMOGLOBIN
9
Q
WEAK SOLUTION OF POTASSIUM CYANIDE AND POTASSIUM FERRICYANIDE
USED FOR MEASUREMENT OF HEMOGLOBIN
A
DRABKIN REAGENT
10
Q
RATIO OF THE VOLUME OF PACKED RBCS TO VOLUME OF WHOLE BLOOD
A
HEMATOCRIT
11
Q
NORMAL RATIO OF HCT
A
50%
12
Q
HCT IS ALSO CALLED
A
PACKED CELL VOLUME/ PCV
13
Q
IT IS EXCLUDED FROM HCT DETERMINATION
A
BUFFY COAT
14
Q
THIS IS USED TO EVALUATE AND CLASSIFY VARIOUS TYPES OF ANEMIAS ACCORDING TO RBC INDICES
A
HEMATOCRIT/PCV
15
Q
THE PERCENTAGE OF RBC IN A VOLUME OF WHOLE BLOOD
A
HEMATOCRIT
16
Q
USES RBC COUNT, HGB AND HCT
-MEAN CELL VOLUME/MCV
-MEAN CELL HEMOGLOBIN/MCH
-MEAN CELL HEMOGLOBIN CONCENTRATION/MCHC
A
RBC INDICES
17
Q
RBC INDICES
A
- MCV
- MCH
3.MCHC
4.RDW
18
Q
MCV IS RECORDED IN WHAT UNIT
A
FEMTOLITERS (fL)
19
Q
RBC INDICES THAT REFLECTS THE RBC DIAMETER ON A WRIGHT STAINED BLOOD FILM
A
MCV
20
Q
MCHC IS RECORDED IN WHAT UNIT
A
GRAMS PER DECILITER (g/dL)
21
Q
RBC INDICES THAT REFLECTS THE RBC STAINING INTENSITY
A
MCHC
22
Q
RBC INDICES THAT REFLECTS THE RBCs CENTRAL PALLOR
A
MCHC
23
Q
MCH IS RECORDED IN WHAT UNIT
A
PICOGRAMS (pg)
24
Q
RBC INDICES THAT EXPRESSES THE MASS OF HEMOGLOBIN PER CELL
A
MCH
25
RBC INDICES THAT PARALLELS THE MCHC
MCH
26
4TH RBC INDEX
RDW
27
RBC INDICES THAT EXPRESSES THE DEGREE OF VARIATION IN RBC VOLUME
RDW
28
EXTREME RBC VOLUME VARIABILITY IN DIAMETER
ANISOCYTOSIS
29
RDW IS BASED ON THE - OF RBC
STANDARD DEVIATION
30
0.5-2.5% OF RBCS THAT EXCEED THE 7-8 AVE DIAMETER
BLUE GRAY COLOR
POLYCHROMATIC ERYTHROCYTES/ RETICULOCYTES
31
THESE ARE NEWLY RELEASED FROM THE RBC PRODUCTION SITE
POLYCHROMATIC ERYTHROCYTES/ RETICULOCYTES
32
INDICATES THE ABILITY OF THE BONE MARROW TO INCREASE RBC PRODUCTION IN ANEMIA CAUSED BY BLOOD LOSS OR EXCESSIVE RBC DESTRUCTION
POLYCHROMATIC ERYTHROCYTES/ RETICULOCYTES
33
USUALLY FROM BM OR LYMPHOID TISSUE DEDICATED TO PROTECT HOST
NEARLY COLORLESS
LEUKOCYTES
34
DECREASED WBC COUNT
LEUKOPENIA
35
INCREASED WBC COUNT
LEUKOCYTOSIS
36
PHAGOCYTIC CELLS, SEGMENTED/MULTI-LOBED NUCLEI
NEUTROPHILS
37
INCREASE IN NEUTROPHILS= BACTERIAL INFECTION
NEUTROPHILIA
38
DECREASE IN NEUTROPHILS= MEDICATIONS/ VIRAL INFECTIONS
NEUTROPENIA
39
ROUND WITH BRIGHT ORANGE-RED CYTOPLASMIC GRANULES
EOSINOPHILS
40
ELEVATED EOSINOPHILS= ALLERGY/PARASITIC INFECTION
EOSINOPHILIA
41
DARK PURPLE, IRREGULAR CYTOPLASMIC GRANULES THAT OBSCURE THE NUCLEUS
BASOPHILS
42
WBC WHICH ITS GRANULES CONTAIN HISTAMINES
BASOPHILS
43
ELEVATED BASOPHILS= HEMATOLOGIC DISEASE
BASOPHILIA
44
RPUND, SLIGHTLY LARGER THAN RBCS NONGRANULAR CYTOPLASM
LYMPHOCYTES
45
ELEVATED LYMPHOCYTES=VIRAL INFECTIONS
LYMPHOCYTOSIS
46
LOW LYMPHOCYTES=DRUG THERAPY/IMMUNODEFICIENCY
LYMPHOCYTOPENIA
47
IMMATURE MACROPHAGE PASSING THE BLOOD
MONOCYTE
48
SLIGHTLY LARGER DIAMETER THAN OTHER WBCS
NUCLEUS: INDENTED/FOLDED
MONOCYTE
49
ELEVATED MONOCYTES=INFECTION/INFLAMMATION
MONOCYTOSIS
50
INCREASE IN WBC ABOVE THE LIMIT
LEUKOCYTOSIS
51
DECREASE IN WBC BELOW THE NORMAL LIMIT
LEUKOPENIA
52
DUE TO
-VIRAL INFECTIONS
-TYPHOID FEVER
-MALARIA
-RAD THERAPY
LEUKOPENIA
53
2-4MM IN DIAMETER
ROUND/OVAL
ANUCLEATE
PLATELETS
54
PLATELTS ALSO REFERRED TO AS
CELL FRAGMENTS
55
TRUE BLOOD CELLS THAT MAINTAIN VESSEL INTEGRITY BY INITIATING VESSEL WALL REPAIRS
PLATELETS/THROMBOCYTES
56
MAJOR CELLS THAT CONTROL HEMOSTASIS
PLATELETS/THROMBOCYTES
57
SERIES OF CELLULAR AND PLASMA-BASED MECHANISMS THAT SEAL WOUNDS
HEMOSTASIS
58
ELEVATED PLATELET COUNT=INFLAMMATION/TRAUMA
THROMBOCYTOSIS
59
LOW PLATELET COUNT=DRUG TREATMENT-LIFE THREATENING
THROMBOCYTOPENIA
60
EASY BRUISING AND UNCONTROLLED HEMORRHAGE
THROMBOCYTOPENIA
61
PROCESS THAT ARE EMPLOYED TO DOCUMENT VALIDITY
QUALITY CONTROL
62
SYSTEM THAT VERIFIES RELIABILITY OF ANALYTICAL TEST RESULTS
QUALITY CONTROL
63
INSTITUTION, COMPREHENSIVE PROGRAM IN ALL AREAS
TO ENSURE QUALITY
QUALITY SYSTEMS
64
PRE ANA, ANA, POST ANA VARIABLES
QUALITY ASSURANCE
65
PROGRAM THAT MONITORS TOTAL TESTING PROCESS
QUALITY ASSURANCE
66
STANDARD EXPRESSION OF CENTRAL TENDENCY
MEAN
66
DATA POINT THAT SEPARATES UPPER HALF FROM LOWER HALF DATA SERIES
MEDIAN
67
ROBUST EXPRESSION OF CENTRAL TENDENCY
MEDIAN
68
DATA POINT THAT APPEARS MOST OFTEN
MODE
69
NOT A TRUE MEASURE OF CENTRAL TENDENCY
MODE
70
EXPRESSES THE DEVIATION OF EACH DATA POINT FROM ITS EXPECTED VALUE
VARIANCE
71
NORMALIZED EXPRESSION OF SD
UNIT EXPRESSION= %
COEFFICIENT OF VARIANCE
CV%
72
MOST COMMONLY USED MEASURE OF DISPERSION IN LABORATORY MEDICINE
CV%
73
COMMONLY USED MEASURE OF DISPERSION- SQUARE ROOT OF THE VARIANCE
STANDARD DEVIATION
74
AN ACTIVITY COMPRISED OF PROCEDURES TO DETERMINE
ACCURACY
SPECIFICITY
PRECISION
LIMITS
LINEARITY
VALIDATION
75
VALIDATION:
AGREEMENT BETWEEN AN ASSAY VALUE
TRUE VALUE
ACCURACY
76
VALIDATION:
EASY TO DEFINE BUT DIFFICULT TO ESTABLISH AND MAINTAIN
ACCURACY
77
VALIDATION:
EXPRESSION OF REPRODUCIBILITY OR DISPERSION
OFTEN EXPRESSED AS SD OR CV%
PRECISION
78
VALIDATION:
RELATIVELY EASY TO MEASURE AND MAINTAIN
PRECISION
79
VALIDATION:
ABILITY TO GENERATE RESULTS PROPORTIONAL TO THE CALCULATED CONCENTRATION OR ACTIVTY
LINEARITY
80
MEASURE OF THE SMALLEST INCREMENT OF THE ANALYTE THAT CAN BE DISTINGUISHED BY THE ASSAY
ANALYTICAL SENSITIVITY
81
THE ABILITY OF THE ASSAY TO DISTINGUISH THE ANALYTE FROM INTERFERING SUBSTANCES
ANALYTICAL SPECIFICITY
82
ASSAY CORRECTLY IDENTIFIES A DISEASE OR CONDITION IN THOSE WHO HAVE IT
TRUE POSITIVE
83
ASSAY INCORRECTLY INDENTIFIES DISEASE OR CONDITION WHEN NONE IS PRESENT
FALSE POSITIVE
84
ASSAY CORRECTLY EXCLUDES A DISEASE OR CONDITION IN THOSE WITHOUT IT
TRUE NEGATIVE
85
ASSAY INCORRECTLY EXCLUDES A DISEASE OR CONDITION WHEN IT IS PRESENT
FALSE NEGATIVE
86
INDV : UNAFFACTED
ASSAY: NEGATIVE
TRUE NEGATIVE
87
INDV : UNAFFACTED
ASSAY: POSITIVE
FALSE POSITIVE
88
INDV : AFFACTED
ASSAY: NEGATIVE
FALSE NEGATIVE
89
INDV : AFFACTED
ASSAY: POSITIVE
TRUE POSITIVE
90
AMOUNT OF SAMPLE NEEDED:
1ML AND ABOVE
MACRO
91
AMOUNT OF SAMPLE NEEDED:
0.1-0.9 ML
MICRO
92
AMOUNT OF SAMPLE NEEDED:
0.01-0.09 ML
ULTRAMICRO
93
AMOUNT OF SAMPLE NEEDED:
0.001-0.009 ML
NANOLITER
94
USED IN MICRO,ULTRAMICRO,NANOLITER METHOD
CAPILLARY P.
SKIN P.
PRICK METHOD
95
MAY CONTAIN TISSUE FLUIDS
SAMPLE IS A MIXTURE OF BLOOD FROM ARTERIOLES, VENULES AND CAPILLARIES
CAPILLARY P.
SKIN P.
PRICK METHOD
96
CAPILLARY P.
SKIN P.
PRICK METHOD
SITE: LATERAL OR MEDIAL PLANTAR HEEL SURFACE
INFANTS <1YO
97
CAPILLARY P.
SKIN P.
PRICK METHOD
SITE: RING/GREAT FINGER, HEEL, EARLOBE
CHILDREN
98
RECOMMENDED SITE FOR ARTERIAL BLOOD
CAPILLARY P.
SKIN P.
PRICK METHOD
EARLOBE
99
CAPILLARY P.
SKIN P.
PRICK METHOD
SITE: PALMAR SURFACE OF THE RING AND MIDDLE FINGER
ADULTS
100
PUNCTURE ON THE FINGER SHOULD BE MADE -- TO THE FINGERPRINT LINES
PERPENDICULAR
101
OFTEN PREFFED BLOOD COLLECTION METJOD FOR GERIATRIC PATIENTS
CAPILLARY P.
SKIN P.
PRICK METHOD
102
HEEL PUNCTURES IN INFANTS SHOULD NOT BE MADE MORE THAN -- DEEP
2MM DEEP
103
ORDER OF DRAW FOR CAPILLARY SPECIMENS
1. BLOOD GASES
2. EDTA TUBES
3. OTHER ADDITIVE MICROTAINERS
4. SERUM
BEDS- SA 'BED' NA PPRICK
104
USED IN MACROMETHOD
MOST COMMONLY USED METHOD
VENIPUNCTURE
105
DEOXYGENATED BLOOD; DARK RED
VENOUS BLOOD
106
TOURNIQUET MUST BE -- INCHES ABOVE THE VENI SITE
3-4 INCHES
107
TOURNIQUET MUST BE LEFT ON FOR NO LONGER THAN - BEFORE VENI
1MIN
108
TOURNIQUET
- OVER -
LEFT OVER RIGHT
109
GAUGE OF NEEDLE IS -- PROPORTIONAL TO BORE SIZE
INVERSELY
110
NEEDLE RANGE FOR DRAWING BLOOD
19-23
111
GAUGE USED MOST COMMON IN NEEDLE SIZE
21 GAUGE
112
NEEDLE LENGTH IN VENIPUNCTURE
1.0-1.5INCHES
113
NEEDLE GAUGE= COLOR
18
PINK
114
NEEDLE GAUGE= COLOR
19
BROWN/IVORY
115
NEEDLE GAUGE= COLOR
20
YELLOW
116
NEEDLE GAUGE= COLOR
21
GREEN
117
NEEDLE GAUGE= COLOR
22
BLACK
118
NEEDLE GAUGE= COLOR
23
BLUE/ BLUE-GREEN
119
ADDITIVES:
HASTENS CLOTTING FACTOR
CLOT ACTIVATORS
120
ADDITIVES:
PREVENTS BLOOD FROM CLOTTING= ANTICOAGULANTS
1. EDTA
2. HEPARIN
3. CITRATE
CHE- 'CHE' AYOKO NGA NANG CLOUT/CLOT
121
ADDITIVES:
INHIBITS METABOLISM OF GLUCOSE
ANTIGLYCOLYTIC AGENT
NaF
122
ADDITIVES:
INERT MATERIAL THAT CHANGE IN VISCOSITY
SEPARATOR GEL
123
STOPPER
ALLOWS BLOOD CLOT IN SERUM
RED=0
124
STOPPER
CC,IS,BB
RED=0
125
STOPPER
ALLOWS BLOOD CLOT IN SERUM WITH BARRIER
USED IN CC
GRAY RED=5
126
STOPPER
BINDS Ca+/ CHELATES CALCIUM
VERSENE
LAVANDER=8
127
STOPPER
ACCELERATES CLOT FORMATION RESULTING IN SERUM
THROMBIN
ORANGE=8
128
STOPPER
BINDS Ca+
SODIUM CITRATE
BLUE=3-4
129
STOPPER
COAG FACTORS
APTT, PT
THROMBIN TIME
BLUE=3-4
130
STOPPER
INHIBITS GLYCOLYTIC ENZYME= ENOLASE
INTERFERES
NA FLUORIDE/ K OXALATE
GRAY=8
131
STOPPER
INHIBITS GLYCOLYTIC ENZYME= GLYCERALDEHYDE
WILL NOT INTERFERE
IODACETATE]
GRAY=8
132
STOPPER
GLUCOSE OGTT/ LACTATE
GRAY=8
133
STOPPER
INHIBITS THROMBIN
HEPARIN
GREEN=8
134
STOPPER
BINDS CALCIUM
BUFFERED SODIUM CITRATE
BLACK=3-4
135
STOPPER
WESTERGREN ESR
BLACK=3-4
136
SITES OF COLLECTION
ROLLS AND BRUISES EASILY
TOUGHER TO PUNCTURE
CEPHALIC
137
SITES OF COLLECTION
VEIN TENDS TO ROLL MORE EASILY
BASILIC
138
SITES OF COLLECTION
WELL ANCHORED, GOOD BLOOD FLOW, BRUISES LESS EASILY
MEDIAN CUBITAL
FEMORAL
WRIST
DORSAL PORTION OF HANDS
139
METHODS OF VENI
USED FROR BLOOD COLL ONLY
SYRINGE
140
METHODS OF VENI
USED FOR BLOOD COLL
STORAGE
MULTIPLE DRAWS
VACUTAINER
141
METHODS OF VENI
COLLECTING SPX FROM CHILDREN
DIFFICULT TO DRAW BLOOD
BUTTERFLY
142
MOST WIDELT USED SYSTEM FOR COLLECTING VENOUS SAMPLES
EVACUATED BLOOD COLLECTION
143
LAVANDER
PLASTIC
K2 EDTA
144
LAVANDER
GLASS
K3 EDTA
145
PINK
PLASTIC
K2 EDTA
146
GREEN
HEPARIN
147
LIGHT BLUE/CLEAR
BUFFERED SODIUM CITRATE
148
K2 EDTA WITH GEL
WHITE
149
USES DOUBLE POINTED NEEDLE
VACUTAINER
150
ORDER OF DRAW: MULTIPLE EVACUATED TUBES (7)
1.YELLOW
2.BLUE
3.RED
4.GREEN
5.LAVANDER
6.WHITE
7.GRAY
'YOU BETTER REMEMBER GIRLS LOVE WORKING GUYS'
151
ANGLE USED IN VENIPUNCTURE
15-30DEGREES
152
COMPLICATIONS: IMMEDIATE LOCAL
PROLONGED TOURNIQUET
HEMOCONCENTRATION
153
COMPLICATIONS: IMMEDIATE LOCAL
EXCESSIVE PULL OF PLUNGER= COLLAPSE
TRANSFIXATION
FAILURE OF BLOOD TO ENTER
154
COMPLICATIONS: IMMEDIATE LOCAL
EXTRAVASATIONS
CLOTTED BLOOD
LEAKAGE OF LARGE AMOUNT OF FLUID IN PUNCTURE SITE
HEMATOMA
155
COMPLICATIONS: IMMEDIATE LOCAL
DISTURBANCES TO BLOOD COLLECTION- BEYOND CONTROL
CIRCULATORY FAILURE
156
COMPLICATIONS: IMMEDIATE LOCAL
EMOTIONAL ANXIETY
SYNCOPE/FAINTING
157
COMPLICATIONS: IMMEDIATE LOCAL
MOST COMMON COMPLICATION IN OBTAINING BLOOD
LEAKAGE OF SMALL AMOUNT FLUID
ECCHYMOSIS/BRUISE
158
COMPLICATIONS
1. THROMBOSIS
2. THROMBOPHEBITIS
LOCAL DELAYED
LATE LOCAL
159
COMPLICATIONS
1. SERUM HEPATITIS
2. AIDS
GENERAL DELAYED
LATE GENERAL
160
COMPLICATION: LATE LOCAL
PERSISTENCE OF CLOT
SEVERAL VENI AT SAME SITE
THROMBOSIS
161
COMPLICATION: LATE LOCAL
RESULT OF INFECTION
THROMBOPHLEBITIS
162
COMPLICATION: LATE GENERAL
TRANSMISSION OF VIRUS BY CONTAMINATED NEEDLES AND SYRINGES
HEPATITIS/AIDS
